ClinicalTrials.gg
CompletedNCT05796180Updated Feb 6, 2026

Sexual Health Counseling Based on the BETTER Model

An interventional study of Behavioral: sexual health counseling based on the BETTER model in Health Knowledge, Attitudes, Practice and Sexuality, sponsored by Lokman Hekim University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-06.

Primary conditionSexualityRegistry: BehaviorReclassifiedWhy we changed it
Registry
Behavior — the first condition term the registry derived for this study.
ClinicalTrials.gg
Sexuality
Why
  1. The study's listed conditions name Sexuality, a narrower term within Behavior.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Lokman Hekim University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

In this study, the investigators wanted to examine the effect of sexual health counseling to women in the postpartum period on the quality of life of the participants.

02

Conditions studied

  • Health Knowledge, Attitudes, Practice
  • Sexuality

Browse trials for

Keywords

  • Sexual Health Counseling
  • Sexual Life Quality
  • Postpartum
  • Postpartum Sexual Life Quality
  • BETTER Model
03

In context

Sexuality Reclassified

130 studies on the registry are indexed under Sexuality; 26 are open to participants now.

This study's enrollment of 60 is below the median of 75 across 79 interventional studies indexed under Sexuality.

Browse Sexuality studies →

Lead sponsor

Lokman Hekim University is the lead sponsor of 43 studies on the registry; 17 are open to participants now.

Compared within Sexuality, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Behavior. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Primiparous,
  • Weeks of gestation 37 weeks and over,
  • Who had a singleton pregnancy,
  • Having a sexual partner/partner,
  • Having started sexual intercourse before starting training,
  • Without a diagnosed chronic disease (DM, HT, Heart disease, etc.),
  • Labour week 37 weeks and over
  • 18 years or older,
  • Able to speak and understand Turkish,

Exclusion criteria

Exclusion Criteria:

  • Edinburgh Postpartum Depression Scale score of 12 and above,
  • To have received training on sexual health and family planning in a hospital or other health institution other than discharge training,
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Behavioral: sexual health counseling based on the BETTER model

    Sexual health counseling based on the BETTER model The content of the research will be discussed by face-to-face interviews with women who gave birth vaginally and applied to the hospital for birth control 8-10 weeks after delivery. Pre-evaluation forms will be applied to women who have agreed to participate in the study to evaluate the inclusion criteria. Women who meet the inclusion criteria will be divided into experimental-control groups using the block randomization method. An appointment will be made for interviews with the women in the experimental group. It is planned that these meetings will be held in the form of online video calls and will last an average of 45 minutes. The final tests will be held 8 weeks after the online meetings are over.

    Behavioral: Behavioral: sexual health counseling based on the BETTER model

  • No intervention
    Control group: Routine postpartum care

    Routine postpartum care Women who gave birth vaginally and applied to the hospital for postpartum controls 8-10 weeks after delivery will be interviewed face-to-face with the women and the content of the research will be mentioned. Pre-evaluation forms will be applied to the women who accepted to participate in the study to evaluate the inclusion criteria. Women who meet the inclusion criteria will be divided into experimental-control groups using the block randomization method. Women in the control group will receive routine postpartum care administered in the hospital. Women in the control group will receive routine postpartum care administered in the hospital. Post-tests will be administered 8 weeks after the first interview.

Interventions

  • BehavioralBehavioral: sexual health counseling based on the BETTER model

    The content of the research will be discussed by face-to-face interviews with women who gave birth vaginally and applied to the hospital for birth control 8-10 weeks after delivery. Pre-evaluation forms will be applied to women who have agreed to participate in the study to evaluate the inclusion criteria. Women who meet the inclusion criteria will be divided into experimental-control groups using the block randomization method. An appointment will be made for interviews with the women in the experimental group. It is planned that these meetings will be held in the form of online video calls and will last an average of 45 minutes. The final tests will be held 8 weeks after the online meetings are over.

06

What researchers measure

Primary outcomes

  1. Postpartum Sexual Life Quality Scale

    The scale is still under development.

    Time frame: 8 week

  2. Arizona Sexual Experiences Scale

    The Arizona Sexual Experiences Scale (ASEX) is a 6-point Likert-type self-report scale and consists of 5 questions. This form reveals the capacity to reach orgasm, the feeling of satisfaction, vaginal wetness, arousal and sexual drive. Each question is scored from 1 to 6. The total score ranges from 5 to 30. Low scores indicate that the sexual response is satisfactory, strong and easy, while high scores indicate the presence of sexual dysfunction. The total scale score is formed by the sum of the scores of the scale items in the scale. The cut-off point of the scale was determined as 11. A score of 5 or more for each item indicates that there is a sexual dysfunction related to that item.

    Time frame: 8 week

  3. VAS satisfaction scale

    Women's satisfaction with sexual life will be evaluated with the visual analog scale (VAS). It shows that women who score high on the scale, which is scored between 0 (very dissatisfied) and 10 (very satisfied), also have high sexual satisfaction.

    Time frame: 8 week

07

Study locations

1 site
  • Lokman Hekim Etlik Hospital
    Ankara, Keçiören, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2024 to primary completion in Feb 2025, 3 months.

Of 54 non-industry interventional studies with no phase under Sexuality, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 32. This study's 3 months is below that.

Counting every sponsor, half of 54 studies reached it within 12 months; a quarter within 6 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 22, 2023
First posted
Apr 3, 2023
StartActual
Nov 18, 2024
Primary completionActual
Feb 23, 2025
CompletionActual
May 23, 2025
Last update
Feb 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05796180
Lead sponsor
Lokman Hekim University
Responsible party
Nurgül ŞİMAL YAVUZ (Lecturer, Lokman Hekim University) — Principal investigator
First posted
Apr 3, 2023
Start date
Nov 18, 2024
Primary completion
Feb 23, 2025
Completion
May 23, 2025
Last update
Feb 6, 2026

Study contacts

Nurgül ŞİMAL YAVUZ, Lecturer
study director · Lokman Hekim University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion